| Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate V Strand, S Cohen, M Schiff, A Weaver, R Fleischmann, G Cannon, R Fox, ... Archives of internal medicine 159 (21), 2542-2550, 1999 | 1068 | 1999 |
| Etanercept versus methotrexate in patients with early rheumatoid arthritis: two‐year radiographic and clinical outcomes MC Genovese, JM Bathon, RW Martin, RM Fleischmann, JR Tesser, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 996 | 2002 |
| Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study DO Clegg, DJ Reda, E Mejias, GW Cannon, MH Weisman, T Taylor, ... Arthritis & Rheumatism 39 (12), 2013-2020, 1996 | 616 | 1996 |
| Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial JM Kremer, MC Genovese, GW Cannon, JR Caldwell, JJ Cush, DE Furst, ... Annals of internal medicine 137 (9), 726-733, 2002 | 524 | 2002 |
| Periodontitis and Porphyromonas gingivalis in Patients With Rheumatoid Arthritis TR Mikuls, JB Payne, F Yu, GM Thiele, RJ Reynolds, GW Cannon, J Markt, ... Arthritis & rheumatology 66 (5), 1090-1100, 2014 | 509 | 2014 |
| Two‐year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate S Cohen, GW Cannon, M Schiff, A Weaver, R Fox, N Olsen, D Furst, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 435 | 2001 |
| Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis: a multicenter, case-control study GS Alarcon, JM Kremer, M Macaluso, ME Weinblatt, GW Cannon, ... Annals of internal medicine 127 (5), 356-364, 1997 | 422 | 1997 |
| Clinical, laboratory, radiographic, and histopathologic features of methotrexate‐associated lung injury in patients with rheumatoid arthritis. A multicenter study with … JM Kremer, GS Alarcón, ME Weinblatt, MV Kaymakcian, M Macaluso, ... Arthritis & Rheumatism 40 (10), 1829-1837, 1997 | 416 | 1997 |
| Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one‐year, randomized, clinical trial in … GW Cannon, JR Caldwell, P Holt, B McLean, B Seidenberg, J Bolognese, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 360 | 2000 |
| Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study DO Clegg, DJ Reda, MH Weisman, WD Blackburn, JJ Cush, GW Cannon, ... Arthritis & Rheumatism 39 (12), 2004-2012, 1996 | 331 | 1996 |
| Rheumatoid factor as a potentiator of anti–citrullinated protein antibody–mediated inflammation in rheumatoid arthritis J Sokolove, DS Johnson, LJ Lahey, CA Wagner, D Cheng, GM Thiele, ... Arthritis & rheumatology 66 (4), 813-821, 2014 | 292 | 2014 |
| Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate CW Carson, GW Cannon, MJ Egger, JR Ward, DO Clegg Seminars in arthritis and rheumatism 16 (3), 186-195, 1987 | 262 | 1987 |
| A genome scan localizes five non–MHC loci controlling collagen–induced arthritis in rats EF Remmers, RE Longman, Y Du, A O'Hare, GW Cannon, MM Griffiths, ... Nature genetics 14 (1), 82-85, 1996 | 248 | 1996 |
| Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study DO Clegg, DJ Reda, MH Weisman, JJ Cush, FB Vasey, ... Arthritis & Rheumatism 39 (12), 2021-2027, 1996 | 236 | 1996 |
| Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity GS Kerr, I Sabahi, JS Richards, L Caplan, GW Cannon, A Reimold, ... The Journal of rheumatology 38 (1), 53-59, 2011 | 217 | 2011 |
| The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double‐blind, sham‐controlled trial DT Felson, MP LaValley, AR Baldassare, JA Block, JR Caldwell, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 168 | 1999 |
| Cause‐specific mortality in male US veterans with rheumatoid arthritis BR England, H Sayles, K Michaud, L Caplan, LA Davis, GW Cannon, ... Arthritis care & research 68 (1), 36-45, 2016 | 165 | 2016 |
| Acute lung disease associated with low‐dose pulse methotrexate therapy in patients with rheumatoid arthritis GW Cannon, JR Ward, DO Clegg, CO Samuelson Jr, TM Abbott Arthritis & Rheumatism: Official Journal of the American College of …, 1983 | 158 | 1983 |
| Methotrexate pulmonary toxicity GW Cannon Rheumatic Disease Clinics of North America 23 (4), 917-937, 1997 | 151 | 1997 |
| Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases Y Kawahito, GW Cannon, PS Gulko, EF Remmers, RE Longman, ... The Journal of Immunology 161 (8), 4411-4419, 1998 | 143 | 1998 |
